Viruses whose genome is RNA are capable of quickly adapting to different conditions because their polymerases have a higher error rate during replication. Most emerging and reemerging viruses such as HIV, Influenza and Marburg belong to this group of viruses.
Introduction
HIV, Influenza and Marburg diseases are classified under emerging infectious diseases. Emerging Infectious Diseases are diseases that have recently increased in incidence or in geographic or host range such as tuberculosis, cholera, dengue fever, malaria, japanese encephalitis, yellow fever and west nile fever, OR are diseases caused by new variants due to evolution but are assigned to known pathogens such as the Human Immunodeficiency virus, new strains of Influenza virus, Severe Acute Respiratory Syndrome and Ebola [1] .
Molecular mechanisms and cellular processes involved in disease pathogenesis, including transmission dynamics and epidemiology, of pathogens that cause reemerging infectious diseases like Marburg, Ebola, and Cholera have yet to be understood. Emerging diseases caused by novel or unrecognized pathogens such as Hantavirus, or those whose transmission modes are under study, such as Ebola and Nipah present yet another challenge [2] .
The mechanisms of disease emergence involve a multiplicity of factors in addition to those at molecular and cellular levels. In addition to virus genetic variation (mutation, reassortment, and recombination), they also include environmental, ocean and air circulation patterns, extreme weather events as well as the ecological and demographic factors that increase the vulnerability of the people to previously unfamiliar microbes [3, 4] .
Demographic, social changes, environmental alterations and efforts to control diseases have added to the increasing problem of emerging infectious diseases like Influenza and Marburg [5] . The use of antibiotics, pesticides, and biological pathogen controls are effecting variations in pathogens, ecological systems, hosts while facilitating disease emergence and/or reemergence [6, 7, 8] . Prime examples are the antibiotic resistant Strepococcus A, Mycobacterium, and E. coli 0:157.
Pathogenic microbes and their hosts also grow and reproduce while adapting in different environmental contexts. This is typified by the Avian influenza that has different hosts (chickens, pigs, ducks and humans in close confines).
Majority of the emerging pathogens (75%) are zoonotic, that is, they can be passed on from animals to humans. Figure 1 shows the different emerging and reemerging diseases globally.
This review discusses the epidemiology of three RNA viral diseases (HIV, Influenza and Marburg) while tracing their global trends down the years.
HIV/AIDS
HIV was first described in June 1981. The pandemic is now 34 years old and it will soon be described as one of the matrix diseases. In 1981, it was an emerging disease and it has continued to reemerge since then because of the frequent viral mutations and evolution [9, 10] . The epidemic has spread globally due to its subtle transmission routes such as sexual, blood-blood contact as well as through the parenteral route. Figure 2 shows the global summary of the epidemic by the year 2014 according to the world health organization.
HIV treatment has been strongly emphasized on to reduce the effects of the disease and in 2014, 1.9 million people enrolled for antiretroviral treatment. This number represents the largest increase ever and it points towards a disease burden that is on the increase. According to the world health organization, the HIV virus has infected close to 78 million people with about 39 million of them having died since the epidemic broke. Among adults aged 15-49 years, about 0.8% of them are living with the virus. However, the disease burden varies between countries and regions. Sub-Saharan Africa is the most
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affected, with about 1 in every 20 adults living with HIV. This accounts for about 71% of the people with HIV globally [11, 12] . In 2013, 1.5 million people joined the ART treatment programed bringing the total number of those on treatment to over 9 million. This has reduced the deaths from HIV/AIDS in the region [13, 14] .
Despite HIV concentration in Sub-Saharan Africa, Asia is likely to be the next disease epicenter even though Asia and the Pacific have made great progress in tackling the epidemic. In Asia, many of the people living with the disease live in twelve nations; Cambodia, China, Indonesia, India, Myanmar, Malaysia, Pakistan, Nepal, Philippines, Papua new guinea, Vietnam and Thailand. India accounts for over 2.1 million people of those living with the disease [15] . New infections on the continent have reduced since 2001 by 26% [16] .
Despite the decrease, the number of new HIV infections in the region has remained unchanged in the last five years. Those going for antiretroviral treatment in the area rose to 1.25 million people by end of 2012. Those going for ART treatment have slowed down since then. This slowdown may have a net effect in the rise of HIV epidemic in the Asia. A rise in the prevalence rate in Asia, with more than one billion people in population, would be catastrophic [16] .
Across Western, Central Europe and North America, HIV prevalence is very low because their nations are capable of reaching to over 80% of those who are in need treatment.
HIV transmission can be prevented through various means. These may involve limiting the number of sexual partners, using condoms, never sharing needles as well as using Pre and Post exposure prophylaxis .
Influenza
Influenza is a misunderstood disease. Episodes of seasonal and inter-pandemic influenza are confronted each and every year. Seasonal influenza is capable of killing almost 500,000 individuals every year throughout the world [19] . In the US, 36,000 people die of influenza every year, over 90% of who are over 65 years20. Due to the frequent antigenic shifts and drifts in the influenza genome, there is a danger of an influenza pandemic. Pandemics occur when there is an exposure to a microbe with no baseline immunity in a population. The influenza pandemic of 1918 to 1919 was the worst in history with over 40 million deaths throughout the world. The seasonal influenza kills majorly older people but the 1919 pandemic killed both young and old. The young deaths were because exposure was to a highly virulent virus that had no background immunity [19] .
The designation of influenza viruses is by the composition of their haemagglutinin and neuraminidase proteins. The major influenza strain in 2005 was the H3N2 strain. Each and every year, the prevalent strains mutate due to the antigenic drift. [20] [21] . Older estimates say 40-50 million people were killed while currently the estimates are at 50 to 100 million people [22, 23] .
Many of the deaths from H1N1 were from bacterial pneumonia which was a secondary infection, haemorrhages and edema in the lungs due to the viral infection [24] .
H1N1 was global, spreading to the Arctic and to the remote Pacific islands. The virus killed 2-20% of those infected against the flu epidemic mortality rate of 0.1% [23, 24] .
H2N2 (Asian flu):
This was a category two outbreak of avian influenza with its origins in China from the year 1956 to 1958. Its emergence is linked to a mutation in a wild ducks strain that was combined with a human strain that was already in existence [25] . Epidemiologically, the virus originated from Guizhou before it spread to Singapore in February 1957, to Hong Kong in April and finally to the United States in June [25, 26] . The estimates of death varied worldly.
3. H3N2 (Hong Kong Flu): Occurred within the years 1968 and 1969. The H3N2 flu emanated from H2N2 due to antigenic shift. Genes in different multiple subtypes re-assorted to a new virus. The flu killed about 1 million people in the whole world [27, 28] . Majority of the death occurred in those who were over 65 years of age [29] The outbreak started in the US, Mexico, Canada and spread to Spain. The disease spread through the spring, and in May 2009, it was confirmed in the whole world [32] . In 2009, the A/H1N1 was declared by WHO as the first influenza pandemic in the 21st century. The A/ H1N1 is a re-assortment of four strains of Influenza A virus subtype H1N1. The pandemic killed more than 18,000 people in over 199 countries by the end of November 2009. However, 284,500 people were killed by the pandemic [32] [33] [34] [35] . From the discussions above, future influenza pandemics are likely to be caused by an avian virus with a hemagluttinin surface protein that lacks immunity in humans.
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Flu can be prevented by avoiding close contact, staying at home when sick, covering the mouth and nose, cleaning the hands as well as vaccination.
Marburg haemorrhagic fever
Marburg haemorrhagic fever is caused by Marburg virus. The disease has a high fatality ratio due to its virulent nature. Its name is derived from the German town Marburg where it was first detected in 1967. It was also detected in Frankfurt, and in Belgrade. The virus has no treatment or vaccine and is transmitted to people through fruit bats then human-human contact for human transmission [36] . The disease simultaneously occurred in the year 1967 in Marburg and Frankfurt in Germany and Belgrade in Serbia where 31 cases were reported with seven of the reported cases dying [37, 38] . In 1975, Marburg haemorrhagic fever was reported in Rhodesia and South Africa where three people were infected [39] . Two cases of the haemorrhagic fever were reported in Kenya in the year 1980 while one case was reported in 1987 [23] . Since the late 1990s, the haemorrhagic fever outbreaks have been mainly concentrated in the Sub-Saharan In case of a Marburg outbreak, it is likely to occur in West Africa or in East Africa. The disease can be prevented by avoiding fruit bats, and sick non-human primates in central Africa, is one way to protect against infection [45] [46] [47] . Measures for prevention of secondary, or person-to-person, transmission are similar to those used for other hemorrhagic fevers. If a patient is either suspected or confirmed to have Marburg hemorrhagic fever, barrier nursing techniques should be used to prevent direct physical contact with the patient. These precautions include wearing of protective gowns, gloves, and masks; placing the infected individual in strict isolation; and sterilization or proper disposal of needles, equipment, and patient excretions.
In conclusion, the above diseases highlight the balance of environmental as well as genetic factors that can impact on the evolutionary patterns of RNA viruses while also illustrating the complexity of these systems. Prediction of future disease emergencies due to RNA viruses is difficult due to the above factors. However, as efforts to improve the capacity to respond to these pathogens are improved, there is the likelihood that these emerging and reemerging diseases can be dealt with in the future.
